Quick Answer
GILEAD SCIENCES, INC. reported Net Income of $8.51 billion for fiscal year 2025.
GILEAD SCIENCES, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $8.51B | +1672.9% |
| 2024 | $480.00M | -91.5% |
| 2023 | $5.67B | +23.4% |
| 2022 | $4.59B | -26.2% |
| 2021 | $6.22B | +4961.0% |
| 2020 | $123.00M | -97.7% |
| 2019 | $5.39B | -1.3% |
| 2018 | $5.46B | +17.9% |
| 2017 | $4.63B | -65.7% |
| 2016 | $13.50B | -25.4% |
| 2015 | $18.11B | +49.6% |
| 2014 | $12.10B | +293.5% |
| 2013 | $3.08B | +18.6% |
| 2012 | $2.59B | -7.5% |
| 2011 | $2.80B | -3.4% |
| 2010 | $2.90B | +10.1% |
| 2009 | $2.64B | +33.2% |
| 2008 | $1.98B | +24.9% |
| 2007 | $1.58B | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.05B | +143.6% | +55.7% |
| June 30, 2025 | $1.96B | +21.4% | +49.0% |
| March 31, 2025 | $1.31B | +131.5% | +4.9% |
| September 30, 2024 | $1.25B | -42.5% | -22.4% |
| June 30, 2024 | $1.61B | +54.4% | +138.7% |
| March 31, 2024 | -$4.17B | -512.9% | -291.3% |
| September 30, 2023 | $2.18B | +21.9% | +108.6% |
| June 30, 2023 | $1.04B | -8.7% | +3.5% |
- GILEAD SCIENCES, INC. showed an increase of +1672.9% in Net Income compared to the prior fiscal year.
- Over the 2007–2025 period, GILEAD SCIENCES, INC.’s net income has grown by 436.9% (from $1.58 billion to $8.51 billion).
- The most recent figure is from GILEAD SCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: